Recursion Pharmaceuticals Inc (RXRX)
6.40
+0.08
(+1.27%)
USD |
NASDAQ |
Nov 01, 16:00
6.405
0.00 (0.00%)
After-Hours: 20:00
Recursion Pharmaceuticals Price to Book Value: 3.091 for Nov. 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 3.091 |
| October 31, 2024 | 3.052 |
| October 30, 2024 | 3.226 |
| October 29, 2024 | 3.255 |
| October 28, 2024 | 3.318 |
| October 25, 2024 | 3.129 |
| October 24, 2024 | 3.071 |
| October 23, 2024 | 3.057 |
| October 22, 2024 | 3.192 |
| October 21, 2024 | 3.264 |
| October 18, 2024 | 3.351 |
| October 17, 2024 | 3.163 |
| October 16, 2024 | 3.385 |
| October 15, 2024 | 3.221 |
| October 14, 2024 | 3.245 |
| October 11, 2024 | 3.197 |
| October 10, 2024 | 2.984 |
| October 09, 2024 | 2.970 |
| October 08, 2024 | 3.11 |
| October 07, 2024 | 2.984 |
| October 04, 2024 | 2.951 |
| October 03, 2024 | 2.926 |
| October 02, 2024 | 2.951 |
| October 01, 2024 | 2.980 |
| September 30, 2024 | 3.182 |
| Date | Value |
|---|---|
| September 27, 2024 | 3.371 |
| September 26, 2024 | 3.462 |
| September 25, 2024 | 3.327 |
| September 24, 2024 | 3.303 |
| September 23, 2024 | 3.221 |
| September 20, 2024 | 3.284 |
| September 19, 2024 | 3.351 |
| September 18, 2024 | 3.337 |
| September 17, 2024 | 3.264 |
| September 16, 2024 | 3.211 |
| September 13, 2024 | 3.173 |
| September 12, 2024 | 3.139 |
| September 11, 2024 | 3.115 |
| September 10, 2024 | 3.052 |
| September 09, 2024 | 2.955 |
| September 06, 2024 | 2.859 |
| September 05, 2024 | 2.980 |
| September 04, 2024 | 2.946 |
| September 03, 2024 | 2.931 |
| August 30, 2024 | 3.516 |
| August 29, 2024 | 3.578 |
| August 28, 2024 | 3.559 |
| August 27, 2024 | 3.675 |
| August 26, 2024 | 3.810 |
| August 23, 2024 | 3.772 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.756
Minimum
May 11 2022
10.83
Maximum
Jul 13 2021
4.255
Average
3.922
Median
May 31 2023
Price to Book Value Benchmarks
| Eli Lilly and Co | 54.59 |
| Pfizer Inc | 1.815 |
| Revance Therapeutics Inc | -- |
| Twist Bioscience Corp | 4.959 |
| NovaBay Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 30.10 |
| PEG Ratio | -0.2071 |
| Price | 6.40 |
| Earnings Yield | -25.62% |
| Market Cap | 1.806B |
| PEGY Ratio | -0.2071 |